Related Experiment Videos
Summary
Beta-D-mannosidase (beta-MAN) deficiency causes beta-mannosidosis. This study identifies two beta-MAN isoforms (A and B) in human urine and kidneys, with differing activity ratios. Isoform B levels may indicate renal tubular damage.
Area of Science:
- Biochemistry
- Enzymology
- Lysosomal storage diseases
Context:
- Beta-D-mannosidase (beta-MAN) is a lysosomal exoglycosidase involved in glycoconjugate degradation.
- Beta-mannosidosis, a rare inherited disorder, results from beta-MAN deficiency, leading to neurological and skeletal issues.
- Previous research focused on serum beta-MAN; this study investigates urinary and renal enzymes.
Purpose:
- To characterize the isoforms of beta-D-mannosidase (beta-MAN) in human urine and kidneys.
- To compare the properties and activity ratios of beta-MAN isoforms A and B from different sources.
- To assess the potential of beta-MAN isoform B as a biomarker for renal tubular damage.
Summary:
- Two distinct beta-MAN isoforms, A (acidic) and B, were identified in human urine and kidney extracts.
- While both isoforms A and B appear identical regardless of origin, their activity ratios (B/A) significantly differ between urine (0.2-0.3) and kidney (15-20).
- Post-kidney transplantation, urinary beta-MAN showed a B/A ratio of approximately 3, with isoforms matching normal renal and urinary types, suggesting B isoform reflects renal tubular status.
Impact:
- Characterization of beta-MAN isoforms provides fundamental biochemical insights.
- The differing isoform activity ratios highlight tissue-specific enzyme processing or function.
- Determination of beta-MAN isoform B levels shows promise as a non-invasive indicator of renal tubular damage in beta-mannosidosis patients.